- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
-
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
-
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
-
March 29-30, 2023ACI Managed Care Disputes and Litigation
-
April 3, 2023Conference of Tribal Lending Commissioners
-
April 11-13, 2023Mass Torts Made Perfect Seminar
-
March 2023Unintended Consequences of Banning Noncompete Agreements
-
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
-
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Medtech Women Minnesota Product Innovation Panel
Sponsored by Robins Kaplan LLP
February 13, 2020
Robins Kaplan is proud to be the 2019-2020 presenting sponsor for the Medtech Women Minnesota chapter. Join us for a panel discussion about how product innovation happens, what the varied approaches are, and how dynamic women leaders can bring creativity and excellence to the forefront as they develop best in class products.
Agenda
Networking
6:30 p.m. – 7:15 p.m.
Panel Discussion
7:15 p.m. – 8:15 p.m.
Moderator:
Archelle Georgiou, M.D.
Chief Health Officer
Starkey Hearing Technologies
Panelists:
Julie Thompson
R&D Director
Boston Scientific
Annie Bloomquist
Chief Product Officer & SVP
Sleep Number Corporation
Cassie Morris
Director of Emerging Technology & Innovation
Peripheral Vascular
Medtronic
Q&A
8:15 p.m. – 8:30 p.m.
Related Publications
March 2023
Unintended Consequences of Banning Noncompete Agreements
Michael Geibelson, Stephen Safranski, Michael Pacelli - Bloomberg Law
March 26, 2023
What I’ll Be Watching for in the Amgen Oral Arguments
Jake Holdreith - IPWatchdog
March 13, 2023
The Antitrust Case that Could Reshape Professional Golf
Ben Steinberg, Jordan Finkel
February 22, 2023
A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
Chris Larus, David Prange, Rajin Olson - The National Law Journal
February 7, 2023
When Monkey Business Slips Into Trademark Infringement
David Martinez and Zac Cohen - Los Angeles & San Francisco Daily Journal
Related News
March 28, 2023
March 10, 2023
Related Events
March 29-30, 2023
April 3, 2023
Conference of Tribal Lending Commissioners
Brendan Johnson - 2023 Annual Conference
April 11-13, 2023
April 19, 2023
FBA Women in MDL, Mass and Class Leadership
Kate Jaycox - FBA Women in MDL, Mass and Class Leadership
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.